IL2 and ovarian cancer: Specifically, Tregs inhibit the proliferation of CD8+ T cells as well as their production of IFNγ and IL-2, counteract the protective effect of cytotoxic T cells in ovarian cancer tissues, thus reversely correlated with patient survival (Curiel et al., 2004).